NED 19 (trans-Ned 19) is a research compound and a member of the beta-carboline class. It acts as a selective antagonist of the nicotinic acid adenine dinucleotide phosphate (NAADP) receptor, which is involved in calcium signaling.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1354235-96-3
Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-2-(methyl-d3)-, (1R-exo)-
research compound
Adenosine, 2′-deoxy-N-(methyl-d3)-
research compound
3,5-Dimethoxybenzaldehyde-d6
research compound
(2H3)ammonia
research compound
(1R,3S)-1-[3-[[4-(2-fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
FUHCEERDBRGPQZ-LBNVMWSVSA-N
COC1=C(C=C(C=C1)[C@@H]2C3=C(C[C@H](N2)C(=O)O)C4=CC=CC=C4N3)CN5CCN(CC5)C6=CC=CC=C6F